Postpartum Interventions to Reduce Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: A Systematic Review

Nicla A Lui, Gajana Jeyaram, Amanda Henry, Nicla A Lui, Gajana Jeyaram, Amanda Henry

Abstract

Introduction: Hypertensive disorders (HDP) affect ~7% of pregnancies. Epidemiological evidence strongly suggests HDP independently increases that individual's risk of later cardiovascular disease (CVD). Focus on reduction or mitigation of this risk has been limited. This review seeks to identify trialed interventions to reduce cardiovascular risk after HDP. Methods: Online medical databases were searched to identify full-text published results of randomized controlled trials (RCT) in women <10 years postpartum after HDP that trialed interventions to reduce cardiovascular risk. Outcomes sought included cardiovascular disease events, chronic hypertension, and other measures of cardiovascular risk such as obesity, smoking status, diet, and physical activity. Publications from January 2008 to July 2019 were included. Results: Two RCTs were identified. One, a trial of calcium vs. placebo in 201 women with calcium commenced from the first follow-up visit outside of pregnancy and continued until 20 weeks' gestation if another pregnancy occurred. A non-significant trend toward decreased blood pressure was noted. The second RCT of 151 women tested an online education programme (vs. general information to control group) to increase awareness of risk factors and personalized phone-based lifestyle coaching in women who had a preeclampsia affected pregnancy in the 5 years preceding enrolment. Significant findings included increase in knowledge of CVD risk factors, reported healthy eating and decreased physical inactivity, however adoption of a promoted heart healthy diet and physical activity levels did not differ significantly between groups. Several observational studies after HDP, and one meta-analysis of studies of lifestyle interventions not performed specifically after HDP but used to extrapolate likely benefits of lifestyle interventions, were identified which supported the use of lifestyle interventions. Several ongoing RCTs were also noted. Discussion: There is a paucity of intervention trials in the early years after HDP to guide evidence-based cardiovascular risk reduction in affected women. Limited evidence suggests lifestyle intervention may be effective, however degree of any risk reduction remains uncertain. Conclusion: Sufficiently powered randomized controlled trials of appropriate interventions (e.g., lifestyle behavior change, pharmacological) are required to assess the best method of reducing the risk of cardiovascular disease in this at-risk population of women.

Keywords: cardiovascular disease; cardiovascular risk reduction; gestational hypertension; hypertensive disorders of pregnancy; lifestyle behavior change; pre-eclampsia; systematic review.

Copyright © 2019 Lui, Jeyaram and Henry.

Figures

Figure 1
Figure 1
PRISMA flow chart (14).

References

    1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br Med J. (2007) 335:974. 10.1136/
    1. Wilson B, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. . Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J. (2003) 326:845. 10.1136/bmj.326.7394.845
    1. Brown MA, Magee LA, Kenny LC, Ananth Karumanchi S, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. (2018) 71:24–43. 10.1161/HYPERTENSIONAHA.117.10803
    1. Mol B, Roberts C, Thangaratinam S, Magee L, de Groot C, Hofmeyr G. Preeclampsia. Lancet. (2016) 387:999–1011. 10.1016/S0140-6736(15)00070-7
    1. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. (2008) 156:918–30. 10.1016/j.ahj.2008.06.042
    1. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. (2013) 28:1–19. 10.1007/s10654-013-9762-6
    1. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. . Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circulation: Cardiovasc Qual Outcomes. (2017) 10:e003497. 10.1161/CIRCOUTCOMES.116.003497
    1. Theilen LH, Fraser A, Hollingshaus M, Schliep K, Varner M, Smith K, et al. . All-cause and cause specific mortality after hypertensive disease of pregnancy. Obstet Gynaecol. (2016) 128:238–44. 10.1097/AOG.0000000000001534
    1. Riise HK, Sulo G, Tell GS, Igland J, Nygård O, Iversen AC, et al. . Association between gestational hypertension and risk of cardiovascular disease among 617 589 Norwegian women. J Am Heart Assoc. (2018) 7:1–13. 10.1161/JAHA.117.008337
    1. Magee L, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group . Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. (2014) 4:104–45. 10.1016/j.preghy.2014.01.003
    1. Feig D, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. Can Med Assoc J. (2008) 179:229–34. 10.1503/cmaj.080012
    1. Peacock AS, Bogossian F, McIntyre HD, Wilkinson S. A review of interventions to prevent Type 2 Diabetes after Gestational Diabetes. Women Birth. (2014) 2014:e7–15. 10.1016/j.wombi.2014.09.002
    1. Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia ADIPS2014. Available online at:
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J. (2009) 339:b2535. 10.1136/bmj.b2535
    1. Hofmeyr GJ, Seuc AH, Betrán AP, Purnat TD, Ciganda A, Munjanja SP, et al. . The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: an exploratory, randomized placebo controlled study. Pregnancy Hypertens. (2015) 5:273–9. 10.1016/j.preghy.2015.04.001
    1. Rich-Edwards JW, Stuart JJ, Skurnik G, Roche AT, Tsigas E, Fitzmaurice GM, et al. . Randomized trial to reduce cardiovascular risk in women with recent preeclampsia. J Women's Health. (2019). 10.1089/jwh.2018.7523. [Epub ahead of print].
    1. Bokslag A, Hermes W, de Groot CJ, Teunissen PW. Reduction of cardiovascular risk after preeclampsia: the role of framing and perceived probability in modifying behavior. Hypertens Pregnancy. (2016) 35:470–3. 10.1080/10641955.2016.1185112
    1. Janmohamed R, Montgomery-Fajic E, Sia W, Germaine D, Wilkie J, Khurana R, et al. . Cardiovascular risk reduction and weight management at a hospital-based postpartum preeclampsia clinic. J Obstetr Gynaecol Can. (2015) 37:330–7. 10.1016/S1701-2163(15)30283-8
    1. van Kesteren F, Visser S, Hermes W, Franx A, van Pampus MG, Poppel MNM, et al. . Prevention of cardiovascular risk in women who had hypertension during pregnancy after 36 weeks gestation. Hypertens Pregnancy. (2015) 34:261–9. 10.3109/10641955.2015.1009544
    1. Berks D, Hoedjes M, Raat H, Duvekot JJ, Steegers EAP, Habbema JDF. Risk of cardiovascular disease after pre-eclpmpsia and the effect of lifestyle interventions: a literature based study. Br J Obstetr Gynaecol. (2012) 120:924–31. 10.1111/1471-0528.12191
    1. Groenhof T, van Rijn B, Franx A, Roeters van Lennep J, Bots M, Lely A. Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when. Eur J Prevent Cardiol. (2017) 26:1735–45. 10.1177/2047487317730472
    1. Leslie M, Briggs L. Preeclampsia and the risk of future vascular disease and mortality: a review. J Midwifery Women's Health. (2016) 61:315–24. 10.1111/jmwh.12469
    1. Van Kesteren F, Visser S, Hermes W, Teunissen P, Franx A, van Pampus M, et al. . Counselling and management of cardiovascular risk factors after preeclampsia. Hypertens Pregnancy. (2016) 35:55–61. 10.3109/10641955.2015.1100311
    1. Paauw N, Luijken K, Franx A, Verhaar M, Lely A. (Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci. (2016) 130:239–46. 10.1042/CS20150567
    1. Adekanle D, Adeyemi A, Olowookere S, Akinleye C. Health workers' knowledge on future vascular disease risk in women with pre-eclampsia in south western Nigeria. BMC Res Notes. (2015) 8:576. 10.1186/s13104-015-1553-6
    1. Zoet G, Koster M, Velthuis B, de Groot C, Maas A, Fauser B, et al. . Determinants of future cardiovascular health in women with a history of preeclampsia. Maturitas. (2015) 82:153–61. 10.1016/j.maturitas.2015.07.004
    1. Rich-Edwards J, Fraser A, Lawlor D, Catov J. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev. (2013) 36:57–70. 10.1093/epirev/mxt006
    1. Seely E, Rich-Edwards J, Lui J, Nicklas J, Saxena A, Tsigas E, Levkoff S. Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study. BMC Pregnancy Childbirth. (2013) 13:240. 10.1186/1471-2393-13-240
    1. Mahendru A, Morris E. Cardiovascular disease in menopause: does the obstetric history have any bearing? Menopause Int. (2016) 19:115–20. 10.1177/1754045313495675
    1. Firoz T, Melnik T. Postpartum evaluation and long term implications. Best Practice Res Clin Obstetr Gynaecol. (2011) 25:549–61. 10.1016/j.bpobgyn.2011.03.003
    1. Hermes W, Franx A, van Pampus MG, Bloemenkamp KW, van der Post JA, Porath M, et al. . 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. BMC Pregnancy Childbirth. (2010) 10:28. 10.1186/1471-2393-10-28
    1. Seely E, Tsigas E, Rich-Edwards J. Preeclampsia and future cardiovascular disease in women: how good are the data and how can we manage our patients? Semin Perinatol. (2015) 39:276–83. 10.1053/j.semperi.2015.05.006
    1. Romundstad P, Magnussen E, Smith G, Vatten L. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. (2010) 122:579–84. 10.1161/CIRCULATIONAHA.110.943407
    1. Magnussen E, Vatten L, Smith G, Romundstad P. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstetr Gynecol. (2009) 114:961–70. 10.1097/AOG.0b013e3181bb0dfc
    1. Buemi M, Bolignano D, Barilla A, Nostro L, Crasci E, Campo S, et al. . Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. J Nephrol. (2008) 21:663.
    1. Hertig A, Watnick S, Strevens H, Boulanger H, Berkane N, Rondeau E. How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol. (2008) 4:503–9. 10.1038/ncpneph0880
    1. Roberts J, Catov J. Pregnancy is a screening test for later life cardiovascular disease. Women's Health Issues. (2010) 22:e123–8. 10.1016/j.whi.2012.01.001
    1. Gooding H, Johnson H. The unchartered frontier: preventive cardiology between the ages of 15 and 35 years. Curr Cardiovas Risk Rep. (2016) 10:29. 10.1007/s12170-016-0509-2
    1. Harvey R, Coffman K, Miller V. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Women's Health. (2015) 11:239–57. 10.2217/WHE.14.64
    1. Smith G, Pudwell J, Roddy M. The Maternal health clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications. J Obstetr Gynaecol Can. (2013) 35:831–9. 10.1016/S1701-2163(15)30841-0
    1. Craici I, Wagner S, Hayman S, Garovic V. Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular disease. Women's Health. (2008) 4:133–5. 10.2217/17455057.4.2.133
    1. Belo L, Santos-Silva A, Quintanilha A, Rebelo I. Similarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise? Curr Med Chem. (2008) 15:2223–9. 10.2174/092986708785747553
    1. Cournot M, Lairez O, Medzech B. Preeclampsia: a challenge also for cardiologists. Ann Cardiol Angeiol. (2018) 67:280–7. 10.1016/j.ancard.2018.03.005
    1. Benschop L, Duvekot J, Versmissen J, van Broekhoven V, Steegers E, Roeters van Lennep J. Blood pressure profile 1 year after severe preeclampsia. Hypertension. (2018) 71:491–8. 10.1161/HYPERTENSIONAHA.117.10338
    1. Keteepe-Arachi T, Sharma S. Preventing stroke and assessing risk in women. Practitioner. (2017) 261:13–7.
    1. Jim B, Karumanchi S. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol. (2017) 37:386–97. 10.1016/j.semnephrol.2017.05.011
    1. Mounier-Vehier C, Madika AL, Boudghene-Stambouli F, Ledieu G, Delsart P, Tsatsaris V. Hypertension in pregnancy and future maternal health. Presse Med. (2016) 45:659–66. 10.1016/j.lpm.2016.05.017
    1. Udenze I. Association of pre-eclampsia with metabolic syndrome and increased risk of cardiovascular disease in women: a systemic review. Niger J Clin Pract. (2016) 19:431. 10.4103/1119-3077.180055
    1. Hu R, Li Y, Di H, Li Z, Zhang C, Shen X, et al. . Risk factors of hypertensive disorders among Chinese pregnant women. J Huazhong Univ Sci Technolog Med Sci. (2015) 35:801–7. 10.1007/s11596-015-1510-6
    1. Murphy M, Bytautiene E, Saade G, Smith G. Alterations to the maternal circulating proteome after preeclampsia. Am J Obstetr Gynecol. (2015) 213:853.e1–9. 10.1016/j.ajog.2015.10.008
    1. Burgess A, Founds S. Cardiovascular implications of preeclampsia. MCN Am J Maternal/Child Nursing. (2016) 41:8–15. 10.1097/NMC.0000000000000204
    1. Fleming K. Pregnancy: window into women's future cardiovascular health. Can Family Phys. (2013) 50:1033–5.
    1. Mehta P, Minissian M, Bairey Merz C. Adverse pregnancy outcomes and cardiovascular risk factor management. Semin Perinatol. (2015) 39:268–75. 10.1053/j.semperi.2015.05.005
    1. Louis J, Saade G. Pregnancy as a window to future health. Semin Perinatol. (2015) 39:253. 10.1053/j.semperi.2015.05.001
    1. Pauli JM, Repke JT. Preeclampsia: short-term and long-term implications. Obstetr Gynecol Clin. (2015) 42:299–313. 10.1016/j.ogc.2015.01.007
    1. Mito A, Arata N, Sakamoto N, Miyakoshi K, Waguri M, Osamura A, et al. . Present status of clinical care for postpartum patients with hypertensive disorders of pregnancy in Japan: findings from a nationwide questionnaire survey. Hypertens Pregnancy. (2015) 34:209–20. 10.3109/10641955.2014.1001902
    1. Ehrenthal D, Rogers S, Goldstein N, Edwards D, Weintraub W. Cardiovascular risk factors one year after a hypertensive disorder of pregnancy. J Women's Health. (2015) 24:23–9. 10.1089/jwh.2014.4811
    1. Gordin D, Forsblom C, Groop P, Teramo K, Kaaja R. Risk factors of hypertensive pregnancies in women with diabetes and the influence on their future life. Ann Med. (2014) 46:498–502. 10.3109/07853890.2014.934274
    1. Hypertension in pregnancy greater risk than previously thought. Pract Midwife. (2014) 17:8.
    1. Gruca-Stryjak K, Cofta S, Wysocka E, Banaszewski J, Breborowicz G. Is there a relationship between pregnancy induced hypertension and obstructive sleep apnea? Case report. Adv Resp Med. (2014) 82:156–62. 10.5603/PiAP.2014.0021
    1. Charlton F, Tooher J, Rye K, Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. (2014) 23:203–12. 10.1016/j.hlc.2013.10.087
    1. Dayer ML, Vocat A, Ditisheim A, Pechère-Bertschi A. Renovascular prognosis of preeclampsia on the mother and the child. Rev Med Suisse. (2013) 9:1628–30.
    1. Heida KY, Franx A, Bots ML. Preeclampsia as cardiovascular risk factor. Ned Tijdschr Geneeskd. (2013) 157:A6522.
    1. Ehrenthal D, Catov J. Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention. Curr Opin Cardiol. (2013) 28:547–53. 10.1097/HCO.0b013e328364298e
    1. Hashemi S, Ramezani Tehrani F, Mehrabi Y, Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). J Obstetr Gynaecol Res. (2013) 39:891–7. 10.1111/j.1447-0756.2012.02069.x
    1. Hermes W, Ket JC, Van Pampus MG, Franx A, Veenendaal MV, Kolster C, et al. . Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis. Obstetr Gynecol Survey. (2012) 67:792–808. 10.1097/OGX.0b013e31827682fc
    1. Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension. (2012) 60:1368–73. 10.1161/HYPERTENSIONAHA.112.198812
    1. Smith G, Pudwell J, Walker M, Wen S. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstetr Gynaecol Can. (2012) 34:830–5. 10.1016/S1701-2163(16)35381-6
    1. Facca TA, Kirsztajn GM, Sass N. Preeclampsia (marker of chronic kidney disease): from genesis to future risks. Braz J Nephrol. (2012) 34:87–93. 10.1590/S0101-28002012000100015
    1. Lazdam M, Davis E, Lewandowski A, Worton S, Kenworthy Y, Kelly B, et al. . Prevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment. J Pregnancy. (2012) 2012:704146. 10.1155/2012/704146
    1. Robbins C, Dietz P, Bombard J, Valderrama A. Gestational hypertension: a neglected cardiovascular disease risk marker. Am J Obstetr Gynecol. (2011) 204:336.e1–9. 10.1016/j.ajog.2010.11.005
    1. Drost J, Maas A, van Eyck J, van der Schouw Y. Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas. (2010) 67:321–6. 10.1016/j.maturitas.2010.08.002
    1. Oyati A, Danbauchi S, Isa M, Alhassan M, Sani B, Anyiam C, et al. . Role of pre-eclamptic toxaemia or eclampsia in hypertensive women attending cardiac clinic of Ahmadu Bello University teaching hospital Zaria, Nigeria. Ann Afr Med. (2008) 7:133–7. 10.4103/1596-3519.55664
    1. Mounier-Vehier C, Delsart P. Pregnancy-related hypertension: a cardiovascular risk situation. Presse Med. (2009) 38:600–8. 10.1016/j.lpm.2008.11.018
    1. Edlow A, Srinivas S, Elovitz M. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstetr Gynecol. (2009) 200:e60–2. 10.1016/j.ajog.2008.10.012
    1. Wenger N. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol. (2014) 113:406–9. 10.1016/j.amjcard.2013.08.054
    1. Beckie T. Ethnic and racial disparities in hypertension management among women. Semin Perinatol. (2017) 41:278–86. 10.1053/j.semperi.2017.04.004
    1. Duffy JY, Hameed AB. Cardiovascular disease screening. Semin Perinatol. (2015) 39:264–7. 10.1053/j.semperi.2015.05.004
    1. Mounier-Vehier C, Madika A, Lecerf C, Letombe B, Delsart P, Ledieu G. Heart, arteries and women, a healthcare pathway for women at cardiovascular risk. J Hypertens. (2017) 35:e286 10.1097/01.hjh.0000523834.73764.d2
    1. Abramson BL, Melvin RG. Cardiovascular risk in women: focus on hypertension. Can J Cardiol. (2014) 30:553–9. 10.1016/j.cjca.2014.02.014
    1. Saade G. Pregnancy as a window to future health. Obstetr Gynecol. (2009) 114:958–60. 10.1097/AOG.0b013e3181bf5588
    1. Sarma A, Scott N. Aspirin use in women: current perspectives and future directions. Curr Atheroscler Rep. (2016) 18:74. 10.1007/s11883-016-0630-1
    1. Moodley J. Maternal deaths due to hypertensive disorders in pregnancy. Best Pract Res Clin Obstetr Gynaecol. (2008) 22:559–67. 10.1016/j.bpobgyn.2007.11.004
    1. Mission J, Marshall N, Caughey A. Pregnancy risks associated with obesity. Obstetr Gynecol Clin N Am. (2015) 42:335–53. 10.1016/j.ogc.2015.01.008
    1. Griffin M, Shennan A. Clinical applications of biomarkers in preeclampsia. Biomarkers Med. (2014) 8:459–70. 10.2217/bmm.14.19
    1. Bassareo P, Mussap M, Bassareo V, Flore G, Mercuro G. Nitrergic system and plasmatic methylarginines: evidence of their role in the perinatal programming of cardiovascular diseases. Clin Chim Acta. (2015) 451:21–7. 10.1016/j.cca.2015.05.011
    1. Sanghavi M, Gulati M. Cardiovascular disease in women: primary and secondary cardiovascular disease prevention. Obstetr Gynecol Clin. (2016) 43:265–85. 10.1016/j.ogc.2016.01.001
    1. Chan S, Pudwell J, Smith G. Effects of preeclampsia on maternal and pediatric health at 11 years postpartum. Am J Perinatol. (2018) 36:806–11. 10.1055/s-0038-1675374
    1. Christensen M, Kronborg C, Carlsen R, Eldrup N, Knudsen U. Early gestational age at preeclampsia onset is associated with subclinical atherosclerosis 12 years after delivery. Acta Obstetr Gynecol Scand. (2017) 96:1084–92. 10.1111/aogs.13173
    1. Bokslag A, Teunissen P, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, et al. . Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstetr Gynecol. (2017) 216:523.e1–7. 10.1016/j.ajog.2017.02.015
    1. White W, Turner S, Bailey K, Mosley T, Kardia S, Wiste H, et al. . Hypertension in pregnancy is associated with elevated homocysteine levels later in life. Am J Obstetr Gynecol. (2013) 209:454.e1–7. 10.1016/j.ajog.2013.06.030
    1. Mongraw-Chaffin M, Cirillo P, Cohn B. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. (2010) 56:166–71. 10.1161/HYPERTENSIONAHA.110.150078
    1. Schenck-Gustafsson K, Rees M. Cardiology for gynecologists—a minireview. Maturitas. (2013) 75:386–91. 10.1016/j.maturitas.2013.04.018
    1. Rantanen K, Tatlisumak T. Stroke in women–oral contraception, pregnancy, and hormone replacement therapy. Curr Vasc Pharmacol. (2013) 11:58–73. 10.2174/157016113804547638
    1. Yoder S, Thornburg L, Bisognano J. Hypertension in pregnancy and women of childbearing age. Am J Med. (2009) 122:890–5. 10.1016/j.amjmed.2009.03.036
    1. Ankumah N, Sibai B. Chronic hypertension in pregnancy: diagnosis, management, and outcomes. Clin Obstetr Gynecol. (2017) 60:206–14. 10.1097/GRF.0000000000000255
    1. Abbasi J. To prevent cardiovascular disease, pay attention to pregnancy complications. JAMA. (2018) 320:1741–3. 10.1001/jama.2018.14645
    1. Maierean S, Mikhailidis D, Toth P, Grzesiak M, Mazidi M, Maciejewski M, et al. . The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review. Exp Opin Investig Drugs. (2018) 27:427–35. 10.1080/13543784.2018.1465927
    1. von Dadelszen P, Magee L. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstetr Gynaecol. (2016) 36:83–102. 10.1016/j.bpobgyn.2016.05.005
    1. Roberge S, Nicolaides K, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin. Obstetr Gynecol Survey. (2013) 68:669–71. 10.1097/OGX.0000000000000004
    1. Haruna M, Matsuzaki M, Ota E, Shiraishi M, Hanada N, Mori R. Guided imagery for treating hypertension in pregnancy. Cochrane Database Syst Rev. (2014) 4:CD011337. 10.1002/14651858.CD011337
    1. Duley L, Henderson-Smart D, Walker G. Interventions for treating pre-eclampsia and its consequences: generic protocol. Cochrane Database Syst Rev. (2009) CD007756. 10.1002/14651858.CD007756
    1. Cleary K, Costantine M, Hebert M, Ahmed M, Brown L, Ren Z, et al. . Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstetr Gynecol. (2016) 214:720.e1–17. 10.1016/j.ajog.2015.12.038
    1. Amoakoh-Coleman M, Ogum-Alangea D, Modey-Amoah E, Ntumy M, Adanu R, Oppong S. Blood pressure patterns and body mass index status in pregnancy: an assessment among women reporting for antenatal care at the Korle-Bu Teaching hospital, Ghana. PLoS ONE. (2017) 12:e0188671. 10.1371/journal.pone.0188671
    1. O'Callaghan K, Kiely M. Systematic review of vitamin d and hypertensive disorders of pregnancy. Nutrients. (2018) 10:294. 10.3390/nu10030294
    1. Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, et al. . Potent vasoconstrictor kisspeptin-10 induces atherosclerotic plaque progression and instability: reversal by its receptor GPR54 antagonist. J Am Heart Assoc. (2017) 6:e005790. 10.1161/JAHA.117.005790
    1. Magro-Malosso E, Saccone G, Di Tommaso M, Roman A, Berghella V. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstetr Gynecol Scand. (2017) 96:921–31. 10.1111/aogs.13151
    1. Al-Rubaie Z, Askie L, Ray J, Hudson H, Lord S. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. BJOG Int J Obstetr Gynaecol. (2016) 123:1441–52. 10.1111/1471-0528.14029
    1. Rayman M, Bath S, Westaway J, Williams P, Mao J, Vanderlelie J, et al. Selenium status in UK pregnant women and its relationship with hypertensive conditions of pregnancy. Br J Nutr. (2015) 113:249–58. 10.1017/S000711451400364X
    1. Duley L. Pre-eclampsia, eclampsia, and hypertension. BMJ Clin Evid. (2011) 2011:1402.
    1. Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care. Dtsch Arztebl Int. (2009) 106:733–8. 10.3238/arztebl.2009.0733
    1. Hauspurg A. Heart Health 4 New Moms: A Randomized Controlled Trial of a Lifestyle Intervention and Home Blood Pressure Monitoring Following Preeclampsia in Overweight and Obese Women [Trial Registration]. Available online at:
    1. Lip G, Felmeden D, Dwivedi G. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev. (2011) CD003186. 10.1002/14651858.CD003186.pub3
    1. Wright J, Musini V, Gill R. First-line drugs for hypertension. Cochrane Database Syst Rev. (2018) CD001841. 10.1002/14651858.CD001841.pub3
    1. Cormick G, Ciapponi A, Cafferata M, Belizán J. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev. (2015) CD010037. 10.1002/14651858.CD010037.pub2
    1. Musini V, Gueyffier F, Puil L, Salzwedel D, Wright J. Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev. (2017) 8:CD008276. 10.1002/14651858.CD008276.pub2
    1. Kurth J, Malik S. Reducing women's cardiovascular disease risk profile. Women's Health. (2015) 113:385–97. 10.2217/WHE.15.10
    1. Davis M, Duvernoy C. How to stay heart healthy in 2011: considerations for the primary prevention of cardiovascular disease in women. Women's Health. (2011) 7:433–51. 10.2217/WHE.11.34
    1. Lee SK, Khambhati J, Varghese T, Stahl EP, Kumar S, Sandesara PB, et al. . Comprehensive primary prevention of cardiovascular disease in women. Clin Cardiol. (2017) 40:832–8. 10.1002/clc.22767
    1. Srivaratharajah K, Abramson B. Identifying and managing younger women at high risk of cardiovascular disease. Can Med Assoc J. (2019) 191:E159–63. 10.1503/cmaj.180053
    1. Hauspurg A, Sutton E, Catov J, Caritis S. Pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension. (2018) 72:202–7. 10.1161/HYPERTENSIONAHA.118.11196
    1. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam D, et al. . Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. (2009) 374:979–88. 10.1016/S0140-6736(09)60736-4
    1. Reimer M, Seliger G. Evaluation of Practicability in Survey and Test Procedures and of Successful Implementation of Complex Interventions–Feasibility Analysis Based on a Pilot Study: Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome [Registered Trial]. Available online at:
    1. Henry A. The BP2 (Blood Pressure Postpartum) Study: A 3-Arm, Randomised Trial of Follow-Up and Lifestyle Behaviour Change Strategies in The First 12 Months After Hypertensive Disorders Of Pregnancy [Registered trial]. Available online at:
    1. Hutchesson M. Evaluating A Healthy Lifestyle Program For Women With a History of Pre-Eclampsia: Be Healthe For Your Heart [Registered Trial]. Available online at:
    1. Lowe SA, Bowyer L, Lust K, McMAhon L, Morton M, North RA, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. (2015) 55:e1–29. 10.1111/ajo.12399
    1. Butte NF, King JC. Energy requirements during pregnancy and lactation. Public Health Nutr. (2005) 8:1010–27. 10.1079/PHN2005793
    1. Shahul S, Tung A, Minhaj M, Nizamuddin J, Wenger J, Mahmood E, et al. . Racial disparities in comorbidities, complications, and maternal and fetal outcomes in women with preeclampsia/eclampsia. Hypertens Pregnancy. (2015) 34:506–15. 10.3109/10641955.2015.1090581
    1. Foundation H. Pregnancy and High Blood Pressure Information: Did You Have High Blood Pressure During Pregnancy? Available online at: : Heart Foundation 2018.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner